PreveCeutical Medical Inc. (PRVCF) Engages NetworkNewsWire for Corporate Communications Solutions
06 févr. 2018 08h30 HE
|
NetworkNewsWire
NEW YORK, Feb. 06, 2018 (GLOBE NEWSWIRE) -- via NetworkWire – PreveCeutical Medical Inc. (CSE:PREV) (OTCQB:PRVCF) (FRANKFURT:18H), a health sciences company that develops innovative preventive...
NetworkNewsWire Announces Publication on Innovative Approaches in Non-Addictive Analgesics
02 févr. 2018 08h30 HE
|
NetworkNewsWire
NEW YORK, Feb. 02, 2018 (GLOBE NEWSWIRE) -- via NetworkWire — NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring...
Pivot Files Three New Provisional Patents for the Delivery of Cannabinoids
01 févr. 2018 04h00 HE
|
Pivot Pharmaceuticals Inc.
VANCOUVER, British Columbia, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Pivot Pharmaceuticals Inc. (CSE:PVOT) (OTCQB:PVOTF) (“Pivot” or the “Company”), is pleased to announce that it has filed three...
VBI Vaccines Announces Changes to its Board of Directors
26 janv. 2018 16h15 HE
|
VBI Vaccines, Inc.
Sam Chawla, of Perceptive Advisors, to resign from VBI Board of DirectorsTomer Kariv, Chairman and CEO of The Pontifax Group, to replace Ran Nussbaum on VBI’s Board of Directors CAMBRIDGE, Mass.,...
BeyondSpring Presents Promising Data for Lead Asset Plinabulin at 2018 ASCO-SITC Clinical Immuno-Oncology Symposium
26 janv. 2018 08h00 HE
|
BeyondSpring, Inc.
Plinabulin and Neulasta have Very Similar Grade 4 Neutropenia Incidence and Duration of Severe Neutropenia (DSN) in the Phase 2 Portion of Phase 2/3 Trial Study 105 with Docetaxel-Induced Neutropenia ...
VBI Vaccines Announces Dosing of First GBM Patient in Phase 1/2a Clinical Study of VBI-1901
17 janv. 2018 08h00 HE
|
VBI Vaccines, Inc.
Two-part Phase 1/2a study of VBI-1901 to enroll patients with recurrent GBM Part A: Dose escalation to enroll up to 18 patientsPart B: Subsequent extension of optimal dose to enroll up to 10...
Pivot Continues To Build Technology Portfolio
17 janv. 2018 04h00 HE
|
Pivot Pharmaceuticals Inc.
VANCOUVER, British Columbia, Jan. 17, 2018 (GLOBE NEWSWIRE) -- Pivot Pharmaceuticals Inc. (CSE:PVOT) (OTCQB:PVOTF) (“Pivot” or the “Company”), and its wholly-owned medical cannabis products...
NetworkNewsAudio Covers NeutriSci International Inc.’s Release on Recent R&D MOU with Scientus Pharma
12 janv. 2018 07h30 HE
|
NetworkNewsWire
NEW YORK, Jan. 12, 2018 (GLOBE NEWSWIRE) -- NetworkNewsAudio, via NetworkNewsWire (“NNW”), a multifaceted financial news and publishing company that delivers a new generation of social communication...
Streetwise Reports Publishes Portfolio Manager’s Biotech Watchlist Picks for 2018
08 janv. 2018 08h45 HE
|
Streetwise Reports Llc
SAN FRANCISCO, Jan. 08, 2018 (GLOBE NEWSWIRE) -- StoneCastle Investment Management has a high-growth fund that invests wherever it finds opportunities, and it is bullish on healthcare. In this...
Axovant to Present at 36th Annual J.P. Morgan Healthcare Conference
05 janv. 2018 07h00 HE
|
Axovant Sciences Ltd.
BASEL, Switzerland, Jan. 05, 2018 (GLOBE NEWSWIRE) -- Axovant Sciences (NASDAQ:AXON) today announced that its Chief Executive Officer David Hung, MD, will be presenting at the 36th Annual J.P....